News
PrecorDx Wins the Venture Challenge Fall 2022!
The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2022 fall edition is PrecorDx! The innovative startup PrecorDx has developed a non-invasive diagnostic platform aimed at reducing hospitalization & slowing disease progression in heart failure.
Amsterdam UMC spin-off PacingCure received EIC Transition funding
Amsterdam UMC spin-off PacingCure received a prestigious EIC Transition grant of 2.5 million euros. PacingCure develops platform gene transfer technologies for the heart and uses these technologies to engin
Review of the MedtechMeeting Q4!
Yesterday Roessingh Research and Development (RRD) hosted the final Medtech Meeting of this year.
Venture Challenge bootcamp 2!
Last week the second three-day bootcamp of the Venture Challenge fall 2022 edition took place in Villa Vennendal.
The lifesciences@work Venture Challenge Spring 2023 call opens soon
Are you a researcher in the life sciences and are you looking to turn your research into a viable product or service that helps patients, physicians or other res
CCMO, CBG and EMA at Lifesciences@work Expert Class!
It was a great pleasure to have welcomed Monique Al, Coordinating/specialist advisor at CCMO, dr. ir.
Two out of 10 winners of the Academic Startup Competition 2022 are Venture Challenge Alumni!
The 10 winners of the Academic Startup Competition ten winners have been named: TargED biopharmaceuticals, Time-travelling Milkman, Carbyon, Quix Quantum bv, Mantispectra bv, Sensip-dx, Exit071, Cellcius bv, Pharmi and ImcoMet bv. Sin
Nutrileads wins Immune Health Award with BeniCaros
Venture Challenge alumnus NutriLeads BV announced today that its patented immune health ingredient BeniCaros® has won the 2022 Nutrition Industry Executive award for the Immune Health category. Each year the
Meet the teams: Venture Challenge Fall 2022
Last week five teams started their Venture Challenge adventure with the first 3-day bootcamp. Already in these three days the teams made huge progress.